| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Starbridge | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $45.69M | Series A-1 | 10/21/2025 | $35M | $290.38M | $20.31 | Craft Ventures, Owl Ventures, Commonweal Ventures, Autotech Ventures | ||||
 | Syndio | Enterprise Software Human Resources | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $82.36M | Series C | 9/27/2021 | $50M | $292.91M | $2.32 | Emerson Collective, Bessemer Venture Partners, Voyager Capital, Candace Parker, Alexi Robichaux, Anita Lynch, Rachel Romer Carlson, 75 & Sunny, Frontier Venture Capital, Operator Collective | ||||
 | Tailor | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $48.53M | Series A | 11/20/2025 | $37M | $169.18M | $9.50 | ANRI, Spiral Capital, JIC Venture Growth Investments, New Enterprise Associates, Y Combinator, i-nest capital, ALPHA, Fukoku CVC Fund, Japan Post Investment, Sumitomo Mitsui Trust Bank, Global Brain, Globis Capital Partners | ||||
 | Tenvie | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $200M | Series A | 1/8/2025 | $158.05M | $391.74M | $1.00 | ARCH Venture Partners, F-Prime Capital, Mubadala Capital | ||||
 | Terion | Energy Clean Energy | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $20M | Series A | 6/18/2026 | $20M | $123.5M | $0.75 | Flagship Pioneering, Stage 1 Ventures | ||||
 | Tizona Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $95.24M | Series B-3 | 1/3/2019 | $15M | $173.78M | $1.60 | AbbVie | ||||
 | Traceable | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $110.11M | Series B-3 | 5/1/2024 | $29.05M | $493.39M | $4.55 | Citi Ventures, IVP, Geodesic Capital, Sorenson Capital, Unusual Ventures | ||||
 | Treasury Prime | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $72.52M | Series C | 2/1/2023 | $40M | $356.39M | $9.92 | BAM Elevate, The Banc Funds Company, Invicta, Deciens, QED, SaaStr | ||||
 | Tune Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $223.37M | Series B-1 | 1/13/2025 | $61.49M | $355.58M | $1.20 | New Enterprise Associates, Yosemite, Regeneron Ventures, Hevolution Foundation | ||||
 | UpLift | Fintech Payments | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $152.61M | Series C-2 | 1/23/2019 | $111.07M | $330.27M | $3.83 | Madrone Capital Partners, Draper Nexus, Ridge Ventures, Highgate Ventures, Barton Asset Management, PAR Capital | ||||
 | Uptycs | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $93M | Series C | 5/26/2021 | $50M | $496.17M | $7.50 | Norwest Venture Partners, Sapphire Ventures, ServiceNow Ventures | ||||
 | Ushur | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $104.67M | Series D | 1/30/2025 | $15M | $227.88M | $0.36 | Doorga Capital | ||||
 | Vendelux | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $66.45M | Series B | 7/8/2026 | $42.06M | $253.39M | $13.49 | Tribeca Venture Partners, S3 Ventures, Pelion Venture Partners, HubSpot Ventures, FirstMark Capital, Cervin Ventures, Correlation Ventures, Alumni Ventures | ||||
 | VentureBeat | Consumer & Lifestyle Media | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $6.73M | Series C-1 | 6/27/2014 | $5.44M | $28.99M | $0.46 | Crosslink, WaldenVC, Formation8, KDDI, Icon Venture Partners | ||||
 | Verge Genomics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $167.53M | Series C* | 9/8/2023 | $42M | $403.75M | $7.19 | Alexion, AstraZeneca, Alumni Ventures, Tenmile | ||||
 | Voltron Data | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $110M | Series A | 2/16/2022 | $88M | $426.03M | $1.61 | Walden Catalyst, BlackRock, Anthos Capital, Battery Ventures, Coatue, GV, Lightspeed Venture Partners, Nepenthe Capital, Redline, The Factory | ||||
 | Wetravel | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $86.2M | Series C | 9/24/2025 | $52.2M | $452.38M | $15.81 | Sapphire Ventures, Left Lane Capital, Base10 Partners, Cross Creek | ||||
 | Aardvark Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $129.13M | Series C | 5/9/2024 | $85M | $267.58M | $1.77 | Decheng Capital, Cormorant Asset Management, Surveyor Capital, SymBiosis, Tetragon Financial Group, Walleye Capital, Laurion Capital Management, LG Technology Ventures, Cantor Ventures, Silver Arc Private Capital, Prader-Willi Syndrome Association, Vickers Venture Partners, Foundation for Prader-Willi Research | ||||
 | Agentio | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $58.25M | Series B | 11/18/2025 | $40M | $340M | $15.48 | Forerunner, Benchmark, Craft Ventures, AlleyCorp, Antler, Starting Line | ||||
 | Akhan Semiconductor | Technology Hardware Computing Hardware | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $54.54M | Series A-1 | 1/24/2023 | $19.46M | $32.52M | $0.26 | Undisclosed Investors | ||||
 | Alleviant Medical | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $182.73M | Series 2 | 1/14/2025 | $91.4M | $258.67M | $1.28 | Gilde Healthcare, Omega Funds, S3 Ventures, RiverVest Venture Partners, Vensana Capital, Longview Ventures, Gilmartin Capital, TMC Corporation | ||||
 | Alveus Therapeutics | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $202.01M | Series A | 2/24/2026 | $197M | $290.11M | $20.00 | New Rhein Healthcare Investors, Andera Partners, Omega Funds, Sanofi Capital, Kurma Partners, Avego Management, Jeito Capital, Novo Holdings, Agent Capital, Seroba Lifesciences, Global BioAccess Fund | ||||
 | ARS Pharmaceuticals | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $76.55M | Series D | 8/31/2021 | $55M | $310.11M | $5.89 | SR One, RA Capital Management, Deerfield | ||||
 | Arthrosi Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $294.54M | Series E | 10/8/2025 | $148.1M | $385.03M | $6.54 | Prime Eight Capital, CR Biotech, HighLight Capital, HM Venture Partners, ReliantTech | ||||